Don't miss an issue! Renew/subscribe for FREE today.
×

Geistlich Biomaterials Introduces the First Xenogeneic / Allogeneic Validated Bone Substitute

Posted on Thursday, December 9, 2021

Setting the standard in regenerative materials, Geistlich Biomaterials has developed groundbreaking product innovations in hard and soft tissue highlighted by Geistlich Bio-Oss®, Geistlich Bio-Gide® and Geistlich Fibro-Gide®. Now, Geistlich Biomaterials is taking another step combining two validated1 regenerative materials for restoring vital bone faster2 – with proven long-term volume stability.3-8

Geistlich Biomaterials introduces the first xenogeneic / allogeneic validated bone substitute,1 Geistlich vallomix™, which conveniently co-packages vallos™, a demineralized cortical allograft and Geistlich Bio-Oss® the leading xenogeneic bone substitute worldwide, with more than 35 years of scientific research.

Verified vallos™ granules and fibers are allogeneic bone substitutes that have been demineralized to ensure high osteoinductive properties.1 A demineralized bone matrix has the advantage of turning over natural bone more rapidly but lacks the volume stability needed in several clinical situations.9

Geistlich Bio-Oss® ensures a treatment solution with demonstrated clinical success, an optimal scaffold for vascularization and new bone formation, and long-term volume stability.3-8

Together, Geistlich vallomix™ offers optimal consistency and performance in demanding clinical situations.1-14 Mix it or layer it – Geistlich vallomix™ is innovation that works with you.

References:

1. Compiled DCI Osteoinductivity Validation Summary_2020. (data on file)

2. Robert A Wood & Brian L Mealey: J Periodontol. 2012 Mar;83(3):329-36. (Clinical Study)

3. Piattelli M et al.: Int J Oral Maxillofac Implants 1999; 14 (6), 835-40. (Clinical Study).

4. Sartori S et al.: Clin Oral Implants Res 2003; 14 (3), 369-72. (Clinical Study).

5. Maiorana C et al.: Int J Periodontics Restorative Dent 2005; 25 (1), 19-25. (Clinical Study).

6. Orsini G et al.: Oral Dis 2007; 13 (6), 586-93. (Clinical Study).

7. Lindgren C et al.: Int J Oral Maxillofac Implants 2009; 24 (6), 1093-100. (Clinical Study).

8. Mordenfeld A et al.: Clin Oral Implants Res 2010; 21 (9), 961-70. (Clinical Study).

9. Serrano CA et al.: Implant Dent. 2018 Aug; 27(4):467-473. (Clinical Study).

10.NCBI Pubmed, Month Year, Search term “Bio-Oss” (1208 hits) (Market research).

11. Berglundh T & Lindhe J: Clin Oral Implants Res 1997; 8 (2), 117-24. (Preclincal Study).

12. Weibrich G et al.: Mund Kiefer Gesichtschir 2000; 4 (3), 148-52. (Preclincal Study).

13. Degidi M et al.: Oral Dis 2006; 12 (5), 469-75. (Clinical Study).

14. Galindo-Moreno P et al.: Clin Oral Implants Res 2010; 21 (2), 221-7. (Clinical Study).







Recent Headlines

© 2024 Conexiant | Privacy Policy